News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
659,638 Results
Type
Article (56505)
Company Profile (181)
Press Release (602952)
Multimedia
Podcasts (115)
Webinars (15)
Section
Business (175073)
Career Advice (2562)
Deals (32572)
Drug Delivery (126)
Drug Development (75000)
Employer Resources (166)
FDA (16931)
Job Trends (14717)
News (309957)
Policy (34654)
Tag
Academia (2808)
Academic (2)
Accelerated approval (13)
Adcomms (33)
Allergies (105)
Alliances (45181)
ALS (114)
Alzheimer's disease (1577)
Antibody-drug conjugate (ADC) (173)
Approvals (16877)
Artificial intelligence (347)
Autoimmune disease (36)
Automation (17)
Bankruptcy (341)
Best Places to Work (11637)
BIOSECURE Act (22)
Biosimilars (139)
Biotechnology (106)
Bladder cancer (101)
Brain cancer (36)
Breast cancer (379)
Cancer (2981)
Cardiovascular disease (246)
Career advice (2161)
Career pathing (33)
CAR-T (188)
CDC (42)
Cell therapy (523)
Cervical cancer (25)
Clinical research (61962)
Collaboration (1046)
Company closure (3)
Compensation (711)
Complete response letters (37)
COVID-19 (2833)
CRISPR (68)
C-suite (363)
Cystic fibrosis (121)
Data (3045)
Decentralized trials (2)
Denatured (30)
Depression (81)
Diabetes (364)
Diagnostics (6473)
Digital health (25)
Diversity (8)
Diversity, equity & inclusion (45)
Drug discovery (141)
Drug pricing (153)
Drug shortages (34)
Duchenne muscular dystrophy (155)
Earnings (67683)
Editorial (50)
Employer branding (21)
Employer resources (149)
Events (107549)
Executive appointments (881)
FDA (18720)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (9)
Funding (954)
Gene editing (143)
Generative AI (30)
Gene therapy (417)
GLP-1 (898)
Government (5195)
Grass and pollen (7)
Guidances (200)
Healthcare (19547)
HIV (43)
Huntington's disease (32)
IgA nephropathy (43)
Immunology and inflammation (187)
Immuno-oncology (13)
Indications (40)
Infectious disease (3033)
Inflammatory bowel disease (157)
Inflation Reduction Act (13)
Influenza (74)
Intellectual property (122)
Interviews (463)
IPO (15467)
IRA (56)
Job creations (3489)
Job search strategy (1803)
Kidney cancer (14)
Labor market (49)
Layoffs (563)
Leadership (26)
Legal (8032)
Liver cancer (81)
Longevity (12)
Lung cancer (410)
Lymphoma (215)
Machine learning (11)
Management (58)
Manufacturing (426)
MASH (98)
Medical device (13355)
Medtech (13360)
Mergers & acquisitions (17861)
Metabolic disorders (937)
Multiple sclerosis (99)
NASH (22)
Neurodegenerative disease (151)
Neuropsychiatric disorders (45)
Neuroscience (2320)
NextGen: Class of 2025 (6797)
Non-profit (4711)
Now hiring (29)
Obesity (488)
Opinion (257)
Ovarian cancer (96)
Pain (121)
Pancreatic cancer (127)
Parkinson's disease (190)
Partnered (21)
Patents (321)
Patient recruitment (170)
Peanut (51)
People (53192)
Pharmaceutical (49)
Pharmacy benefit managers (25)
Phase I (19020)
Phase II (26637)
Phase III (21253)
Pipeline (1727)
Policy (245)
Postmarket research (2650)
Preclinical (7602)
Press Release (59)
Prostate cancer (153)
Psychedelics (46)
Radiopharmaceuticals (250)
Rare diseases (528)
Real estate (5271)
Recruiting (66)
Regulatory (24243)
Reports (39)
Research institute (2484)
Resumes & cover letters (412)
Rett syndrome (9)
RNA editing (9)
RSV (61)
Schizophrenia (101)
Series A (162)
Series B (114)
Service/supplier (10)
Sickle cell disease (67)
Special edition (20)
Spinal muscular atrophy (146)
Sponsored (37)
Startups (3378)
State (1)
Stomach cancer (17)
Supply chain (83)
Tariffs (70)
The Weekly (84)
Vaccines (913)
Venture capital (60)
Weight loss (325)
Women's health (50)
Worklife (20)
Date
Today (118)
Last 7 days (503)
Last 30 days (1761)
Last 365 days (31388)
2025 (18014)
2024 (34941)
2023 (39248)
2022 (50348)
2021 (54931)
2020 (53702)
2019 (46591)
2018 (35374)
2017 (31694)
2016 (31403)
2015 (35372)
2014 (28306)
2013 (23343)
2012 (25064)
2011 (25599)
2010 (23354)
Location
Africa (877)
Alabama (62)
Alaska (7)
Arizona (213)
Arkansas (12)
Asia (37949)
Australia (6629)
California (7432)
Canada (2281)
China (640)
Colorado (318)
Connecticut (337)
Delaware (202)
Europe (89164)
Florida (1145)
Georgia (265)
Hawaii (3)
Idaho (52)
Illinois (658)
India (30)
Indiana (380)
Iowa (18)
Japan (233)
Kansas (109)
Kentucky (22)
Louisiana (15)
Maine (73)
Maryland (1047)
Massachusetts (5638)
Michigan (244)
Minnesota (449)
Mississippi (4)
Missouri (102)
Montana (22)
Nebraska (24)
Nevada (80)
New Hampshire (69)
New Jersey (2121)
New Mexico (21)
New York (2068)
North Carolina (1147)
North Dakota (9)
Northern California (3324)
Ohio (230)
Oklahoma (15)
Oregon (35)
Pennsylvania (1615)
Puerto Rico (16)
Rhode Island (33)
South America (1229)
South Carolina (35)
South Dakota (1)
Southern California (2793)
Tennessee (123)
Texas (1084)
United States (27860)
Utah (217)
Virginia (198)
Washington D.C. (76)
Washington State (654)
West Virginia (4)
Wisconsin (78)
659,638 Results for "myriad women s health".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
“Perfect Patient” Industry Burdens; Exits and Investment in Women’s Health
In this episode of Denatured, BioSpace’s Head of Insights Lori Ellis and Miruna Sasu, CEO of COTA, discuss the challenges of inclusion and exclusion criteria of clinical trial patients, and reflect on current investment approaches around women’s health.
March 13, 2025
·
1 min read
·
Lori Ellis
Press Releases
June Health Launches to Redefine Women’s Health as a Strategic Employer Benefit
June 17, 2025
·
5 min read
Business
Trials and Capital: Women’s Health and APAC’s Healthcare Revolution
In this episode of Denatured, BioSpace’s Head of Insights Lori Ellis, Miguel Forte and Ali Pashazadeh discuss the industry’s need to catch up with women’s health issues and the innovative lead the APAC region has taken in clinical trials.
January 2, 2025
·
1 min read
·
Lori Ellis
IN PARTNERSHIP WITH DIA
Economic Challenges, Strategic Investments: Reshaping the Women’s Health Landscape
In this episode presented by DIA, BioSpace’s head of insights Lori Ellis discusses how collaboration and investment shape the the future of women’s health with Martin Hodosi, partner at Kearney and Melissa Laitner, director of strategic initiatives at the National Academy of Medicine.
April 24, 2025
·
1 min read
·
Lori Ellis
Business
Myriad Genetics Appoints Dallas Reed, MD, FACOG, FACMG as Principal Medical Advisor of Women’s Health
Myriad Genetics, Inc., a leader in genetic testing and precision medicine, announced the appointment of Dallas Reed, MD, FACOG, FACMG as Principal Medical Advisor to its women’s health business unit, effective immediately.
February 15, 2024
·
3 min read
Editorial
Advice From Women in Biopharma: ‘Resilience Is a Critical Feature’
When talking to some of the most impressive women in biopharma, the conversation inevitably turned to what these women wanted other entrepreneurs to know. Here’s the best of the best of that advice.
July 23, 2025
·
3 min read
·
Annalee Armstrong
Press Releases
Clairity Becomes the First FDA-Authorized AI Platform for Breast Cancer Prediction – Historic Milestone for Women’s Health
June 2, 2025
·
5 min read
Women’s Health
Organon’s Endometriosis Drug Discontinued After Failing To Improve Pain
The women’s health focused company acquired the drug for up to $954 million in 2021 through the acquisition of Forendo Pharma.
July 2, 2025
·
1 min read
·
Annalee Armstrong
Press Releases
Bayer Highlights New Data from Oncology and Women’s Health Portfolios at 2025 ASCO Annual Meeting
May 21, 2025
·
19 min read
Press Releases
Aspira Women’s Health Partners with Dorsata to Offer Access to 300+ Women’s Health Practices, 1.5 Million + New Patients
June 17, 2025
·
6 min read
1 of 65,964
Next
